Fulcrum Capital LLC Amgen Inc Transaction History

Fulcrum Capital LLC

$451 Million
Q3 2024

A detailed history of Fulcrum Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Fulcrum Capital LLC holds 9,989 shares of AMGN stock, worth $2.94 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

9,989

Previous 10,065 0.76%

Holding current value

$2.94 Million

Previous $3.14 Million 2.35%

% of portfolio

0.71%

Previous 0.73%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $23,512 - $25,640	-76 Reduced 0.76%	9,989 $3.22 Million
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $104,837 - $127,404	399 Added 4.13%	10,065 $3.14 Million
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $61,302 - $73,999	228 Added 2.42%	9,666 $2.75 Million
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $778,095 - $877,783	-3,043 Reduced 24.38%	9,438 $2.72 Million
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $110,418 - $137,087	-505 Reduced 3.89%	12,481 $3.35 Million
Q2 2023 Jul 27, 2023	SELL	$214.27 - $253.37 $81,636 - $96,533	-381 Reduced 2.85%	12,986 $2.88 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $198,243 - $241,625	878 Added 7.03%	13,367 $3.23 Million
Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $286,516 - $364,053	1,251 Added 11.13%	12,489 $0
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $131,982 - $148,852	-588 Reduced 4.97%	11,238 $2.53 Million
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $2.49 Million - $2.77 Million	10,776 Added 1026.29%	11,826 $2.88 Million
Q3 2021 Oct 21, 2021	SELL	$212.27 - $248.7 $60,921 - $71,376	-287 Reduced 21.47%	1,050 $223,000
Q2 2021 Jul 30, 2021	SELL	$233.58 - $259.14 $28,029 - $31,096	-120 Reduced 8.24%	1,337 $326,000
Q1 2021 Apr 12, 2021	SELL	$221.91 - $258.6 $134,921 - $157,228	-608 Reduced 29.44%	1,457 $363,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $204,695 - $243,755	946 Added 84.54%	2,065 $475,000
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $221,349 - $271,626	1,119 New	1,119 $264,000
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $179,506 - $238,074	-985 Closed	0 $0
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $31,219 - $40,128	-165 Reduced 14.35%	985 $237,000
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $200,226 - $239,913	1,150 New	1,150 $223,000
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $200,226 - $239,913	-1,150 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $19,170 - $22,472	-115 Reduced 9.09%	1,150 $212,000
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $36,174 - $40,776	200 Added 18.78%	1,265 $240,000
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $197,333 - $222,467	1,065 New	1,065 $221,000
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $252,281 - $294,822	-1,489 Closed	0 $0
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $251,328 - $280,810	1,489	1,489 $259,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulcrum Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulcrum Capital LLC with notifications on news.

Account

Fulcrum Capital LLC Amgen Inc Transaction History